Infectious Disease Therapeutics Market is poised to touch USD 154.18 Billion by 2023
Infectious Disease Therapeutics Market Size and Growth Rate:
As per the latest reports published by Research Cosmos, Infectious Disease Therapeutics Market was valued at USD 105.13 Billion in 2018 and projected to reach USD 154.18 Billion by 2023 growing at a CAGR of 7.96% during the forecast period 2018 to 2023.
Browse details of 94 number of pages research report developed on Infectious Disease Therapeutics Market @ https://www.researchcosmos.com/reports/global-infectious-disease-therapeutics-market-size-status-and-forecast-2025/2964923
Infectious Disease Therapeutics Market Growth Drivers and Restraints:
The main factors driving market growth are the proliferation of infectious diseases, the increasing use of direct-acting antivirals, the rise in health care expenditures, the growth in the geriatric population, the increase in health awareness and augmenting public funds in developing countries. The main factor that hinders the growth of the market is the generic erosion, and the expiration of the patents of medicines against infectious diseases.
Geographical Analysis of Infectious Disease Therapeutics Market:
North America is expected to represent the largest proportion of the market, followed by the Asia-Pacific region and Europe due to the increasing incidence of infectious diseases and the aging of the population. The Asia-Pacific region is expected to register the highest compound annual growth rate during the review period due to increased government funding in its emerging countries such as India and China.
The health service delivery system in the Asia-Pacific region, the majority financed by private funds, is the most prone to economic recessions, although it is partially offset by the fact that much of traditional medicine. China is the largest market for the infectious disease therapies market in Asia-Pacific, accounting for 27% of the market in 2016.
Ask For Free Sample of the report @ https://www.researchcosmos.com/request/global-infectious-disease-therapeutics-market-size-status-and-forecast-2025/2964923
Key Players of Infectious Disease Therapeutics Market:
Some of the major companies operating in global Infectious disease Therapeutics Market are F. Hoffmann-La Roche, Gilead Sciences, GlaxoSmithKline, Johnson & Johnson, Merck & Co, Pfizer, Achillion Pharmaceuticals, Novartis, AbbVie, Astellas Pharma, AstraZeneca, Auritec Pharmaceuticals, Bayer, Bristol-Myers Squibb, Chimerix Pharmaceuticals, Cubist, Eli Lilly, Isis Pharmaceuticals, Mitsubishi Tanabe Pharma, pSivida, and Sanofi.
Infectious Disease Therapeutics Market Segmentation:
By Product:
- HIV infection
- Influenza
- Malaria
- Tuberculosis
- Hepatitis
- HPV infection
By Segment:
- Hospital
- Clinic
- Research Institute
- Laboratories
By Region:
- North America
- South America
- Europe
- Asia Pacific
- Middle East and Africa
For any queries, inquire more @ https://www.researchcosmos.com/inquire/global-infectious-disease-therapeutics-market-size-status-and-forecast-2025/2964923
About Us:
Research Cosmos is a provider of standard and customized market research, business intelligence and consulting services across more than 100 domains in different industries of the world. We host the trending market reports of the world’s top-notch publishing companies, offering services to a wide range of customers from students to fortune 500 companies and discloses the hidden opportunities in every leading industry of the world.
Contact:
Kevin Stewart
Global Sales Manager
Research Cosmos